Symbols / IKT $1.82 +8.98% Inhibikase Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
IKT Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics to modify the course of cardiopulmonary diseases, with a primary focus on pulmonary arterial hypertension (PAH), a progressive, life-threatening disease characterized by pulmonary vascular remodeling and elevated pulmonary vascular resistance. It offers IKT-001, a novel oral prodrug of imatinib mesylate designed for the treatment of pulmonary arterial hypertension (PAH) was designed to improve areas of the molecule that might play a role in the gastrointestinal side effects associated with imatinib, while maintaining systemic exposure and efficacy through oral administration. The company has completed non-human primate safety studies and a bioequivalence clinical study in healthy volunteers, establishing dose equivalence with imatinib. IKT-001 is currently being evaluated in a global, adaptive Phase 3 clinical trial (IMPROVE-PAH), with endpoints including pulmonary vascular resistance and 6-minute walk distance. Inhibikase Therapeutics, Inc. entered into a collaborative research and development agreement with Sphaera Pharma Pte. Ltd., which was subsequently assigned to Pivot Holding LLC, for prodrug technology development and maintains an exclusive license for IKT-001. The company was founded in 2008 and is headquartered in Wilmington, Delaware.

Fundamentals
Scroll to Statements
Market Cap 240.30M Enterprise Value 131.40M Income -48.26M Sales — Book/sh 1.02 Cash/sh 1.05
Dividend Yield — Payout 0.00% Employees 35 IPO — P/E 3.47 Forward P/E -4.79
PEG — P/S — P/B 1.79 P/C — EV/EBITDA -2.86 EV/Sales —
Quick Ratio 21.54 Current Ratio 21.70 Debt/Eq — LT Debt/Eq — EPS (ttm) -0.49 EPS next Y -0.38
EPS Growth — Revenue Growth — Earnings 2026-05-13 ROA -20.53% ROE -36.04% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 132.03M Shs Float 85.42M Short Float 22.91%
Short Ratio 9.92 Short Interest — 52W High 2.37 52W Low 1.33 Beta 0.86 Avg Volume 2.00M
Volume 952.85K Target Price $5.75 Recom Strong_buy Prev Close $1.67 Price $1.82 Change 8.98%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.75
Mean price target
2. Current target
$1.82
Latest analyst target
3. DCF / Fair value
$-1.30
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.82
Low
$3.00
High
$8.00
Mean
$5.75

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-04 init Ladenburg Thalmann — → Buy $4
2026-01-21 init B of A Securities — → Buy $6
2025-12-17 init Freedom Broker — → Buy $3
2025-12-11 init Cantor Fitzgerald — → Overweight $4
2025-03-28 reit HC Wainwright & Co. Neutral → Neutral —
2025-02-12 down HC Wainwright & Co. Buy → Neutral —
2024-11-08 init Jefferies — → Buy $8
2024-10-14 main HC Wainwright & Co. Buy → Buy $5
2024-08-16 main HC Wainwright & Co. Buy → Buy $15
2024-05-21 main HC Wainwright & Co. Buy → Buy $23
2024-03-07 reit HC Wainwright & Co. Buy → Buy $27
2024-03-05 main HC Wainwright & Co. Buy → Buy $27
2023-08-15 reit HC Wainwright & Co. Buy → Buy $27
2023-06-30 main HC Wainwright & Co. Buy → Buy $27
News
RSS: Latest IKT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-11-21 SANDS CAPITAL LIFE SCIENCES PULSE FUND II, L.P. Beneficial Owner of more than 10% of a Class of Security — 2,068,965 $1.45 $2,999,999
2025-02-21 MUNSHI AMIT D Director — 57,265 $0.00 $0
2024-10-21 MUNSHI AMIT D Director — 365,000 $2.22 $810,300
2024-10-21 KUSH ARVIND Director — 145,000 $2.22 $321,900
2024-10-21 BELLINI ROBERTO Director — 1,460,000 $2.22 $3,241,200
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
53.35
+86.60%
28.59
+42.31%
20.09
+10.82%
18.13
Research And Development
29.79
+73.11%
17.21
+26.38%
13.62
+13.16%
12.03
Selling General And Administration
23.56
+107.01%
11.38
+69.02%
6.73
+8.28%
6.22
Other Operating Expenses
—
—
-0.26
-111.03%
-0.12
Total Expenses
53.35
+86.60%
28.59
+42.31%
20.09
+10.82%
18.13
Operating Income
-53.35
-86.60%
-28.59
-42.31%
-20.09
-10.82%
-18.13
Total Operating Income As Reported
-51.97
-81.80%
-28.59
-42.31%
-20.09
-10.82%
-18.13
EBITDA
-53.29
-86.56%
-28.56
-43.44%
-19.91
-9.88%
-18.12
Normalized EBITDA
-54.66
-91.37%
-28.56
-43.44%
-19.91
-9.88%
-18.12
Reconciled Depreciation
0.06
+130.28%
0.03
-85.19%
0.18
+2538.67%
0.01
EBIT
-53.35
-86.60%
-28.59
-42.31%
-20.09
-10.82%
-18.13
Total Unusual Items
1.37
0.00
—
—
Total Unusual Items Excluding Goodwill
1.37
0.00
—
—
Special Income Charges
1.37
0.00
—
—
Restructuring And Mergern Acquisition
-1.37
0.00
—
—
Net Income
-48.26
-75.36%
-27.52
-44.62%
-19.03
-5.40%
-18.05
Pretax Income
-48.26
-75.36%
-27.52
-44.62%
-19.03
-5.40%
-18.05
Net Non Operating Interest Income Expense
3.72
+247.47%
1.07
+0.78%
1.06
+1324.94%
0.07
Interest Expense Non Operating
—
—
—
—
Net Interest Income
3.72
+247.47%
1.07
+0.78%
1.06
+1324.94%
0.07
Interest Expense
—
—
—
—
Interest Income Non Operating
3.72
+247.47%
1.07
+0.78%
1.06
+1324.94%
0.07
Interest Income
3.72
+247.47%
1.07
+0.78%
1.06
+1324.94%
0.07
Other Income Expense
1.37
—
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-48.26
-75.36%
-27.52
-44.62%
-19.03
-5.40%
-18.05
Net Income From Continuing Operation Net Minority Interest
-48.26
-75.36%
-27.52
-44.62%
-19.03
-5.40%
-18.05
Net Income From Continuing And Discontinued Operation
-48.26
-75.36%
-27.52
-44.62%
-19.03
-5.40%
-18.05
Net Income Continuous Operations
-48.26
-75.36%
-27.52
-44.62%
-19.03
-5.40%
-18.05
Normalized Income
-49.63
-80.35%
-27.52
-44.62%
-19.03
-5.40%
-18.05
Net Income Common Stockholders
-48.26
-75.36%
-27.52
-44.62%
-19.03
-5.40%
-18.05
Diluted EPS
—
-1.16
+63.29%
-3.16
+26.17%
-4.28
Basic EPS
—
-1.16
+63.29%
-3.16
+26.17%
-4.28
Basic Average Shares
—
23.71
+293.35%
6.03
+42.74%
4.22
Diluted Average Shares
—
23.71
+293.35%
6.03
+42.74%
4.22
Diluted NI Availto Com Stockholders
-48.26
-75.36%
-27.52
-44.62%
-19.03
-5.40%
-18.05
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
181.20
+83.78%
98.60
+579.69%
14.51
-41.83%
24.94
Current Assets
180.11
+82.94%
98.45
+592.78%
14.21
-41.69%
24.37
Cash Cash Equivalents And Short Term Investments
178.76
+83.27%
97.54
+636.06%
13.25
-42.51%
23.05
Cash And Cash Equivalents
139.22
+146.45%
56.49
+516.36%
9.17
+27.50%
7.19
Cash Financial
—
—
—
7.19
Other Short Term Investments
39.54
-3.68%
41.05
+904.51%
4.09
-74.23%
15.86
Receivables
—
—
0.00
-100.00%
0.04
Accounts Receivable
—
—
0.00
-100.00%
0.04
Prepaid Assets
1.00
+1132.34%
0.08
-63.01%
0.22
-80.33%
1.12
Other Current Assets
0.34
-58.45%
0.83
+11.81%
0.74
+352.23%
0.16
Total Non Current Assets
1.10
+637.27%
0.15
-49.75%
0.30
-47.70%
0.57
Net PPE
0.00
-100.00%
0.15
-49.75%
0.30
-47.70%
0.57
Gross PPE
0.00
-100.00%
0.21
-37.05%
0.33
-42.99%
0.57
Accumulated Depreciation
0.00
+100.00%
-0.06
-86.27%
-0.03
-352.97%
-0.01
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.00
-100.00%
0.10
-54.35%
0.22
-32.38%
0.33
Machinery Furniture Equipment
0.00
-100.00%
0.10
+0.00%
0.10
+15.89%
0.09
Other Properties
—
—
0.02
-89.01%
0.15
Non Current Prepaid Assets
1.00
0.00
—
—
Other Non Current Assets
0.10
—
—
—
Total Liabilities Net Minority Interest
8.30
+122.33%
3.73
+5.80%
3.53
-9.54%
3.90
Current Liabilities
8.30
+122.33%
3.73
+8.58%
3.44
-6.95%
3.70
Payables And Accrued Expenses
1.98
-24.66%
2.62
-1.10%
2.65
-14.13%
3.09
Payables
1.16
+22.80%
0.94
-8.32%
1.03
-10.65%
1.15
Accounts Payable
1.16
+22.80%
0.94
+45.81%
0.65
-43.82%
1.15
Other Payable
—
—
0.38
—
Current Accrued Expenses
0.82
-51.30%
1.68
+3.46%
1.62
-16.20%
1.94
Pensionand Other Post Retirement Benefit Plans Current
3.26
+226.50%
1.00
+57.26%
0.64
+38.14%
0.46
Current Debt And Capital Lease Obligation
—
0.11
-26.37%
0.15
+2.92%
0.15
Current Debt
—
—
—
—
Other Current Borrowings
—
—
—
—
Current Capital Lease Obligation
0.00
-100.00%
0.11
-26.37%
0.15
+2.92%
0.15
Current Deferred Liabilities
—
—
—
—
Current Deferred Revenue
—
—
—
—
Other Current Liabilities
3.06
—
—
—
Total Non Current Liabilities Net Minority Interest
0.00
0.00
-100.00%
0.09
-56.13%
0.21
Long Term Debt And Capital Lease Obligation
—
0.00
-100.00%
0.09
-56.13%
0.21
Long Term Capital Lease Obligation
—
0.00
-100.00%
0.09
-56.13%
0.21
Stockholders Equity
172.90
+82.26%
94.87
+764.16%
10.98
-47.81%
21.04
Common Stock Equity
172.90
+82.26%
94.87
+764.16%
10.98
-47.81%
21.04
Capital Stock
0.13
+89.86%
0.07
+1021.27%
0.01
+46.45%
0.00
Common Stock
0.13
+89.86%
0.07
+1021.27%
0.01
+46.45%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
131.69
+89.86%
69.36
+1021.23%
6.19
+47.13%
4.20
Ordinary Shares Number
131.69
+89.86%
69.36
+1021.23%
6.19
+47.13%
4.20
Additional Paid In Capital
315.43
+66.67%
189.25
+143.03%
77.87
+13.19%
68.80
Retained Earnings
-142.68
-51.11%
-94.42
-41.14%
-66.90
-39.75%
-47.87
Gains Losses Not Affecting Retained Earnings
0.02
+158.53%
-0.04
-4347.21%
0.00
-99.16%
0.10
Other Equity Adjustments
0.02
+158.53%
-0.04
-4347.21%
0.00
-99.16%
0.10
Total Equity Gross Minority Interest
172.90
+82.26%
94.87
+764.16%
10.98
-47.81%
21.04
Total Capitalization
172.90
+82.26%
94.87
+764.16%
10.98
-47.81%
21.04
Working Capital
171.81
+81.39%
94.72
+779.26%
10.77
-47.90%
20.68
Invested Capital
172.90
+82.26%
94.87
+764.16%
10.98
-47.81%
21.04
Total Debt
0.00
-100.00%
0.11
-53.99%
0.24
-31.62%
0.35
Capital Lease Obligations
0.00
-100.00%
0.11
-53.99%
0.24
-31.62%
0.35
Net Tangible Assets
172.90
+82.26%
94.87
+764.16%
10.98
-47.81%
21.04
Tangible Book Value
172.90
+82.26%
94.87
+764.16%
10.98
-47.81%
21.04
Interest Payable
—
—
—
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-27.79
-45.11%
-19.15
-5.88%
-18.09
-4.23%
-17.35
Cash Flow From Continuing Operating Activities
-27.79
-45.11%
-19.15
-5.88%
-18.09
-4.23%
-17.35
Net Income From Continuing Operations
-48.26
-75.36%
-27.52
-44.62%
-19.03
-5.40%
-18.05
Depreciation Amortization Depletion
0.06
+130.28%
0.03
-85.19%
0.18
+2538.67%
0.01
Depreciation
0.06
+130.28%
0.03
-85.19%
0.18
+2538.67%
0.01
Depreciation And Amortization
0.06
+130.28%
0.03
-85.19%
0.18
+2538.67%
0.01
Other Non Cash Items
-1.37
—
0.03
-52.93%
0.07
Stock Based Compensation
15.31
+88.07%
8.14
+1527.64%
0.50
+9.17%
0.46
Asset Impairment Charge
7.36
0.00
—
—
Operating Gains Losses
—
—
—
—
Gain Loss On Investment Securities
—
—
—
—
Change In Working Capital
0.06
-72.71%
0.20
-12.71%
0.23
+37.14%
0.17
Change In Receivables
—
0.00
-100.00%
0.04
-43.24%
0.07
Changes In Account Receivables
—
0.00
-100.00%
0.04
-43.24%
0.07
Change In Prepaid Assets
-1.39
-190.36%
-0.48
-156.74%
0.84
+156.32%
0.33
Change In Payables And Accrued Expense
1.55
+123.76%
0.69
+207.62%
-0.64
-151.20%
-0.26
Change In Accrued Expense
1.40
+233.57%
0.42
+403.34%
-0.14
+56.36%
-0.32
Change In Payable
0.15
-45.98%
0.27
+153.88%
-0.50
-921.58%
0.06
Change In Account Payable
0.15
-45.98%
0.27
+153.88%
-0.50
-921.58%
0.06
Change In Other Working Capital
—
—
—
0.04
Change In Other Current Assets
0.01
-94.77%
0.12
+13.51%
0.11
+179.64%
0.04
Change In Other Current Liabilities
-0.11
+14.79%
-0.13
-16.78%
-0.11
-1026.56%
-0.01
Investing Cash Flow
2.05
+105.55%
-37.00
-417.45%
11.66
+172.83%
-16.01
Cash Flow From Continuing Investing Activities
2.05
+105.55%
-37.00
-417.45%
11.66
+172.83%
-16.01
Net PPE Purchase And Sale
-0.01
0.00
+100.00%
-0.01
+94.15%
-0.24
Purchase Of PPE
-0.01
0.00
+100.00%
-0.01
+94.15%
-0.24
Capital Expenditure
-0.45
—
-0.01
+94.15%
-0.24
Net Investment Purchase And Sale
2.51
+106.77%
-37.00
-417.06%
11.67
+174.04%
-15.76
Purchase Of Investment
-39.09
+35.33%
-60.46
-105.45%
-29.43
-41.98%
-20.73
Sale Of Investment
41.60
+77.39%
23.45
-42.94%
41.10
+728.07%
4.96
Net Intangibles Purchase And Sale
-0.44
0.00
—
—
Purchase Of Intangibles
-0.44
0.00
—
—
Financing Cash Flow
108.46
+4.82%
103.48
+1131.14%
8.41
+4204.63%
-0.20
Cash Flow From Continuing Financing Activities
108.46
+4.82%
103.48
+1131.14%
8.41
+4204.63%
-0.20
Net Issuance Payments Of Debt
—
—
0.00
+100.00%
-0.25
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
0.00
+100.00%
-0.25
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Short Term Debt Payments
—
—
0.00
+100.00%
-0.25
Net Short Term Debt Issuance
—
—
0.00
+100.00%
-0.25
Net Common Stock Issuance
107.62
+4.00%
103.48
+1111.18%
8.54
0.00
Proceeds From Stock Option Exercised
0.85
0.00
0.00
-100.00%
0.04
Net Other Financing Charges
—
—
-0.14
—
Changes In Cash
82.73
+74.81%
47.33
+2294.25%
1.98
+105.89%
-33.56
Beginning Cash Position
56.49
+516.36%
9.17
+27.50%
7.19
-82.36%
40.75
End Cash Position
139.22
+146.45%
56.49
+516.36%
9.17
+27.50%
7.19
Free Cash Flow
-28.24
-47.47%
-19.15
-5.79%
-18.10
-2.87%
-17.59
Interest Paid Supplemental Data
—
—
0.00
-100.00%
0.00
Amortization Of Securities
-0.94
0.00
—
—
Common Stock Issuance
107.62
+4.00%
103.48
+1111.18%
8.54
0.00
Issuance Of Capital Stock
107.62
+4.00%
103.48
+1111.18%
8.54
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category